Caption Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-134,800
Closed -$3.59M 1935
2025
Q4
$3.36M Buy
+134,800
New +$3.4M 0.02% 644
2025
Q2
Sell
-23,500
Closed -$548K 1795
2025
Q1
$595K Buy
+23,500
New +$615K 0.01% 1060
2024
Q2
Sell
-24,900
Closed -$686K 1427
2024
Q1
$691K Buy
24,900
+7,500
+43% +$208K 0.01% 818
2023
Q4
$501K Buy
+17,400
New +$526K 0.01% 965
2022
Q3
Sell
-17,400
Closed -$846K 1765
2022
Q2
$912K Buy
17,400
+14,500
+500% +$739K 0.01% 911
2022
Q1
$150K Buy
+2,900
New +$150K ﹤0.01% 1299
2020
Q4
Sell
-393,564
Closed -$13.7M 1191
2020
Q3
$13.7M Buy
+393,564
New +$13.8M 0.32% 64

Other funds holding PFE

Caption Management's PFE Position: Q1 2026 in Review

Caption Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 134,800 shares — an estimated $3.59M sold.

Caption Management first reported a position in PFE in Q3 2020 and held it in 7 quarters. The position peaked at $13.7M in Q3 2020. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Caption Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 134,800 Pfizer shares in Q1 2026, an estimated $3.59M.
  • Caption Management first reported a position in Pfizer in Q3 2020 and held it in 7 quarters.
  • Caption Management's Pfizer position peaked at $13.7M in Q3 2020.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.